Get my own profile
Public access
View all5 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Andrew L. HopkinsCEO, ExscientiaVerified email at exscientia.co.uk
- Cristian BologaResearch Professor, University of New MexicoVerified email at salud.unm.edu
- Oleg UrsuVertex PharmaceuticalsVerified email at vrtx.com
- sean ekinsCollaborations Pharmaceuticals, Inc.Verified email at collaborationspharma.com
- Tudor OpreaCEO, Expert Systems IncVerified email at expertsystems.inc
- Michael SaporitoConsultant to the Biopharmaceutical IndustryVerified email at intervirrx.com
- Liliana Ostopovici-HalipThe Institute of Chemistry, TimisoaraVerified email at acad-icht.tm.edu.ro
- Jeremy J YangUniversity of New MexicoVerified email at salud.unm.edu
- Scott BoyerCEO ChemotargetsVerified email at chemotargets.com
- Yvonne MartinSenior Volwiler Research Felllow, Abbott Laboratories (Retired) Volunteer, Neglected DiseasesVerified email at abbvie.com
- Garland R. MarshallProfesso of Biochemistry and Molecular Biophysics, Washington UniversityVerified email at biochem.wustl.edu
- Gilbert RishtonChief Science Officer, Cardax / co-Founder and Chief Chemist, Cognition TherapeuticsVerified email at cardaxpharma.com
- Barry BuninCollaborative Drug DiscoveryVerified email at collaborativedrug.com
- Krishna DoleHead of Scientific Informatics, Collaborative Drug DiscoveryVerified email at collaborativedrug.com
- Clifton E Barry IIINIAIDVerified email at niaid.nih.gov
- Cynthia DowdAssociate Professor, George Washington UniversityVerified email at email.gwu.edu
- Binghe WangGeorgia State UniversityVerified email at gsu.edu
- James McKerrowDean, University of California San DiegoVerified email at health.ucsd.edu
- Christopher SouthanInformatics, Medicines Discovery CatapultVerified email at md.catapult.org.uk
- Alex M. ClarkPresident, Molecular Materials InformaticsVerified email at molmatinf.com